SMA Type 2
Showing 1 - 25 of >10,000
SMA II Trial in China (GC101)
Not yet recruiting
- SMA II
- GC101
-
Beijing, China
- +4 more
Jun 15, 2023
Spinal Muscular Atrophy Trial in Reims (Monthly assessments of functional motor abilities by a trained therapist, Nusinersen)
Recruiting
- Spinal Muscular Atrophy
- Monthly assessments of functional motor abilities by a trained therapist
- Nusinersen
-
Reims, FranceDamien JOLLY
Mar 16, 2022
Type 2 Spinal Muscular Atrophy Trial in Worldwide (OAV101, Sham control)
Recruiting
- Type 2 Spinal Muscular Atrophy
- OAV101
- Sham control
-
Norfolk, Virginia
- +10 more
Aug 17, 2022
Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type II Trial in Worldwide (Apitegromab)
Not yet recruiting
- Spinal Muscular Atrophy
- +9 more
-
Phoenix, Arizona
- +26 more
Nov 15, 2022
Bulbar Function, Speech And Communication Development in SMA
Not yet recruiting
- SMA1
- (no location specified)
Jul 12, 2023
Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2 Trial in United States (Apitegromab,
Recruiting
- Spinal Muscular Atrophy
- +9 more
- Apitegromab
- Placebo
-
Phoenix, Arizona
- +9 more
Jul 11, 2022
Spinal Muscular Atrophy Trial in Beijing, Shenyang, Suzhou (GC101)
Recruiting
- Spinal Muscular Atrophy
- GC101
-
Beijing, China
- +3 more
Apr 22, 2023
Muscular Atrophy, Spinal, Type II, Muscular Atrophy, Spinal, Type III Trial in France (Strength force measurment, Time tests,
Not yet recruiting
- Muscular Atrophy, Spinal, Type II
- Muscular Atrophy, Spinal, Type III
- Strength force measurment
- +6 more
-
Angers, France
- +5 more
Apr 20, 2023
Spinal Muscular Atrophy Trial in Liège (Actimyo)
Enrolling by invitation
- Spinal Muscular Atrophy
- Actimyo
-
Liège, BelgiumCentre Hospitalier Régional de la Citadelle
May 11, 2021
Type2 Diabetes Trial in Las Vegas (Continuous Glucose Monitor (CGM), Activity Tracker, Coaching)
Completed
- Type2 Diabetes
- Continuous Glucose Monitor (CGM)
- +2 more
-
Las Vegas, NevadaSouthwest Medical Associates
Apr 27, 2021
Spinal Muscular Atrophy Trial in France (Spinraza intrathecal injection)
Recruiting
- Spinal Muscular Atrophy
- Spinraza intrathecal injection
-
Lyon, Auvergne Rhone Alpes, France
- +6 more
Jul 1, 2022
Infantile Spinal Muscular Atrophy of Type 2 or 3 Trial in Garches (Physical exercise in a swimming pool during 6 months)
Completed
- Infantile Spinal Muscular Atrophy of Type 2 or 3
- Physical exercise in a swimming pool during 6 months
-
Garches, Hauts-de-Seine, FranceRaymond Poincaré Hospital
Apr 30, 2021
Type 1 Diabetes Trial in Washington (SMA visits)
Recruiting
- Type 1 Diabetes
- SMA visits
-
Washington, District of ColumbiaChildren's National Hospital
Aug 8, 2022
Oxidative Capacity and Exercise Tolerance in Ambulatory SMA
Completed
- Spinal Muscular Atrophy Type 3
- Mitochondrial Myopathy
-
New York, New YorkColumbia University Medical Center
Mar 7, 2022
Muscle Atrophy Trial in Milano (Amifampridine Phosphate 10 MG Oral Tablet)
Terminated
- Muscle Atrophy
- Amifampridine Phosphate 10 MG Oral Tablet
-
Milano, Lombardy, ItalyNeurological Institute Carlo Besta
Mar 14, 2022
Spinal Muscular Atrophy Trial (OAV101)
Recruiting
- Spinal Muscular Atrophy
- OAV101
-
Montreal, Quebec, Canada
- +1 more
Jan 31, 2023
Spinal Muscular Atrophy Type I Trial in Japan, Korea, Republic of, Taiwan (Onasemnogene Abeparvovec-xioi)
Completed
- Spinal Muscular Atrophy Type I
- Onasemnogene Abeparvovec-xioi
-
Tokyo, Japan
- +3 more
Nov 18, 2022
Pancreatic Adenocarcinoma Trial in Birmingham (No Periadventitial dissection of the SMA, Periadventitial dissection of the SMA)
Recruiting
- Pancreatic Adenocarcinoma
- No Periadventitial dissection of the SMA
- Periadventitial dissection of the SMA
-
Birmingham, County (Optional), United KingdomUniversity Hospitals Birmingham NHS Foundation Trust
May 20, 2021
Type 1 Diabetes Trial in Bern (SMA bolus option, Exactly estimated carbohydrate content bolus option)
Not yet recruiting
- Type 1 Diabetes
- SMA bolus option
- Exactly estimated carbohydrate content bolus option
-
Bern, SwitzerlandDepartment of Diabetes, Endocrinology, Nutritional Medicine and
Aug 10, 2022
Type 2 Diabetic Patients: Real-life Study on Effectiveness and
Not yet recruiting
- Diabete Type 2
- (no location specified)
Nov 2, 2023
Glucagon-like Peptide-1 Receptor Agonists According to Type 2
Recruiting
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Bari, ItalyAzienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023
Diabetes Trial in Chiayi City (Shared Medical Appointments)
Completed
- Diabetes Mellitus
- Shared Medical Appointments
-
Chiayi City, Chiayi, TaiwanPin-Fan Chen
Sep 4, 2023
Muscular Atrophy, Spinal Trial in Milano (Amifampridine Phosphate, Placebo Oral Tablet)
Completed
- Muscular Atrophy, Spinal
- Amifampridine Phosphate
- Placebo Oral Tablet
-
Milano, Lombardy, ItalyNeurological Institute Carlo Besta
May 28, 2021